Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon E Sprague

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Addiction Biology|February 21, 2024
The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorderMatthew L Banks, Jon E Sprague
Forensic Science International|March 19, 2016
Technical note: The effects of Bluestar(®) and luminol when used in conjunction with tetramethylbenzidine or phenolphthaleinMakayla Luedeke, Emily Miller, Jon E Sprague
Brain Sciences|March 28, 2024
Dopamine Concentration Changes Associated with the Retrodialysis of Methylone and 3,4-Methylenedioxypyrovalerone (MDPV) into the Caudate PutamenRobert Goldsmith, Amal Aburahma, Jon E Sprague
The American Journal of Drug and Alcohol Abuse|March 8, 2017
University students' attributions for abstinence from synthetic cannabinoids and synthetic cathinonesKirstin J Lauritsen, Harold Rosenberg, Jon E Sprague
Toxicology and Applied Pharmacology|March 12, 2023
Designer benzodiazepine rat pharmacokinetics: A comparison of alprazolam, flualprazolam and flubromazolamJeremy R Canfield, David F Kisor, Jon E Sprague
Personalized Medicine|May 23, 2018
Drug safety assurance through clinical genotyping: near-term considerations for a system-wide implementation of personalized medicineMichael D Kane, John A Springer, Jon E Sprague
Data in Brief|November 20, 2018
Pharmacokinetic data of synthetic cathinones in female Sprague-Dawley ratsGregory G Grecco, David F Kisor, Jon E Sprague
American Journal of Pharmaceutical Education|December 24, 2010
Bulimic learningJoseph A Zorek, Jon E Sprague, Nicholas G Popovich
Toxicology Letters|October 25, 2016
Cooling down the bath salts: Carvedilol attenuation of methylone and mephedrone mediated hyperthermiaLuke C Zona, Gregory G Grecco, Jon E Sprague
Drug and Alcohol Dependence|May 18, 2025
Enhanced pharmacokinetic and pharmacodynamic effects of combining p-fluorofentanyl and fentanylJeremy R Canfield, Kayla K Fry, Jon E Sprague
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Addiction Biology|February 21, 2024
The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorderMatthew L Banks, Jon E Sprague
Forensic Science International|March 19, 2016
Technical note: The effects of Bluestar(®) and luminol when used in conjunction with tetramethylbenzidine or phenolphthaleinMakayla Luedeke, Emily Miller, Jon E Sprague
Brain Sciences|March 28, 2024
Dopamine Concentration Changes Associated with the Retrodialysis of Methylone and 3,4-Methylenedioxypyrovalerone (MDPV) into the Caudate PutamenRobert Goldsmith, Amal Aburahma, Jon E Sprague
The American Journal of Drug and Alcohol Abuse|March 8, 2017
University students' attributions for abstinence from synthetic cannabinoids and synthetic cathinonesKirstin J Lauritsen, Harold Rosenberg, Jon E Sprague
Toxicology and Applied Pharmacology|March 12, 2023
Designer benzodiazepine rat pharmacokinetics: A comparison of alprazolam, flualprazolam and flubromazolamJeremy R Canfield, David F Kisor, Jon E Sprague
Personalized Medicine|May 23, 2018
Drug safety assurance through clinical genotyping: near-term considerations for a system-wide implementation of personalized medicineMichael D Kane, John A Springer, Jon E Sprague
Data in Brief|November 20, 2018
Pharmacokinetic data of synthetic cathinones in female Sprague-Dawley ratsGregory G Grecco, David F Kisor, Jon E Sprague
American Journal of Pharmaceutical Education|December 24, 2010
Bulimic learningJoseph A Zorek, Jon E Sprague, Nicholas G Popovich
Toxicology Letters|October 25, 2016
Cooling down the bath salts: Carvedilol attenuation of methylone and mephedrone mediated hyperthermiaLuke C Zona, Gregory G Grecco, Jon E Sprague
Drug and Alcohol Dependence|May 18, 2025
Enhanced pharmacokinetic and pharmacodynamic effects of combining p-fluorofentanyl and fentanylJeremy R Canfield, Kayla K Fry, Jon E Sprague
Pageof 10